Clinical trial
A Trial Investigating the Efficacy and Safety of LC-Z300-01 on Proteinuria in Patients With Diabetic Kidney Disease
NCT06686758 is registered in ClinicalTrials.gov with Shanghai Changzheng Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Trial Investigating the Efficacy and Safety of LC-Z300-01 on Proteinuria in Patients With Diabetic Kidney Disease
- Lead sponsor
- Shanghai Changzheng Hospital
- Phase
- Not applicable
- Overall status
- Not yet recruiting
- Start date
- April 30, 2025
- Completion date
- May 31, 2026
- Enrollment
- 60 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
diabetic kidney disease